Avecho Biotechnology Ltd (AVE) — Cash Flow Reinvestment Rate
Avecho Biotechnology Ltd (AVE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$2.27 Million. See Avecho Biotechnology Ltd (AVE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avecho Biotechnology Ltd Cash Flow Reinvestment Rate (1993–2025)
Historical reinvestment intensity for Avecho Biotechnology Ltd across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Avecho Biotechnology Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Avecho Biotechnology Ltd (1993–2025)
Year-by-year capital reinvestment analysis for Avecho Biotechnology Ltd. See AVE free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | AU$0.00 | AU$1.10 Million | AU$0.00 | ▼ -100.0% |
| 2019 | 0.01x | AU$16.21K | AU$1.19 Million | AU$5.15K | — |
| 1993 | 0.00x | AU$0.00 | AU$23.00K | AU$0.00 | — |